Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the biopharmaceutical development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 2 293 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Development & Commercialization of Innovative Therapies889.90101.9%1,117100.6% +25.5%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States444.0850.8%507.5445.7% +14.29%
Europe178.7520.5%252.6322.7% +41.34%
Latin America142.3116.3%147.4713.3% +3.63%
Rest of World124.7714.3%209.2118.8% +67.68%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé632005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA582012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD592009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Elaine J. Heron PhD, MBA692002Independent Non-Executive Director
Michael G. Grey702005Independent Non-Executive Director
Richard A. Meier572006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD652007Independent Non-Executive Director
Alan J. Lewis, PhD712005Independent Non-Executive Director
Dennis Joseph Slamon MD, PhD682014Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 172,866,495 172,218,323 99.6% 0 0.0% 99.6%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 19,643,043 11.4%
The Vanguard Group, Inc. 13,207,286 7.64%
Sands Capital Management LLC 9,380,802 5.43%
Jennison Associates LLC 9,254,206 5.35%
BlackRock Fund Advisors 8,661,674 5.01%
PRIMECAP Management Co. 7,885,948 4.56%
Fidelity Management & Research Co. 7,543,465 4.36%
Baker Bros. Advisors LP 4,806,483 2.78%
SSgA Funds Management, Inc. 3,743,112 2.17%
Temasek Holdings Pte Ltd. (Investment Management) 3,472,712 2.01%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.03%7,533,334 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..5.47%15 103
BIOGEN INC5.16%59 348
CSL LIMITED23.00%42 869
ALEXION PHARMACEUTICAL..-2.53%26 787
GRIFOLS SA17.32%14 943
CHONGQING ZHIFEI BIOLO..--.--%4 160
3SBIO INC22.37%3 125
JIANGXI BOYA BIO-PHARM..--.--%2 548
ABCAM PLC6.78%2 079
PROMETIC LIFE SCIENCES..-2.19%1 115
HUGEL INC--.--%1 027
BIOTEST AG22.92%803
PHARMA MAR SA9.23%710
ANIKA THERAPEUTICS INC-13.50%620
SYROS PHARMACEUTICALS ..25.66%357
CHEMOCENTRYX INC0.00%356
SYNDAX PHARMACEUTICALS..80.33%236
KADMON HOLDINGS INC-36.45%176
MEDIWOUND LTD39.76%140
CARDIOME PHARMA CORP3.03%98
ALIMERA SCIENCES INC36.11%95
Sector Biopharmaceuticals
BioMarin Pharmaceutical In : Connections
Rapidscan Pharma Solutions, Inc.
Ziarco Group Ltd.
Sutro Biopharma, Inc.
Ziarco Pharma Ltd.
Reneo Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc.
Jonsson Comprehensive Cancer Center
Zephyrus Biosciences, Inc.
Batu Biologics, Inc.
Cytochroma, Inc.
Selventa, Inc.
DiaVacs, Inc.
Balance Therapeutics, Inc.
Cellastra, Inc.
Sosei Co. Ltd.
Biotechnology Innovation Organization
Biothera, Inc.
Capella Therapeutics, Inc.
Rincon Pharmaceuticals, Inc.
Translational Research In Oncology
Targazyme, Inc.
Itero Biopharmaceuticals LLC
Scancell Ltd.
AbSci LLC
University of California, Los Angeles
Reform Biologics LLC
David Geffen School of Medicine
Company contact information
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415 506 6700
Fax : +1 415 382 7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem